In one paragraphArticle in Journal of gastrointestinal cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Shravan NadkarniGastrointestinal and Hepatopancreaticobiliary services, Department of Surgical oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Dr E. Borges Marg, Parel, Mumbai, 400 012, India.ORCID https://orcid.org/0000-0002-6811-0076 Shraddha PatkarGastrointestinal and Hepatopancreaticobiliary services, Department of Surgical oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Dr E. Borges Marg, Parel, Mumbai, 400 012, India.ORCID https://orcid.org/0000-0001-8489-6825 M Rajgopal AcharyaGastrointestinal and Hepatopancreaticobiliary services, Department of Surgical oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Dr E. Borges Marg, Parel, Mumbai, 400 012, India.ORCID https://orcid.org/0000-0001-5543-3485 Swapnil PatelGastrointestinal and Hepatopancreaticobiliary services, Department of Surgical oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Dr E. Borges Marg, Parel, Mumbai, 400 012, India.ORCID https://orcid.org/0000-0001-6807-3271 Amir ParrayGastrointestinal and Hepatopancreaticobiliary services, Department of Surgical oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Dr E. Borges Marg, Parel, Mumbai, 400 012, India.ORCID https://orcid.org/0000-0002-1779-8261 Aekta ShahGastrointestinal and Hepatopancreaticobiliary services, Department of Surgical oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Dr E. Borges Marg, Parel, Mumbai, 400 012, India.
Mahesh GoelGastrointestinal and Hepatopancreaticobiliary services, Department of Surgical oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Dr E. Borges Marg, Parel, Mumbai, 400 012, India. drmaheshgoel@gmail.com.ORCID https://orcid.org/0000-0002-7510-1573 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Weight LossAgedAnorexiaChemotherapy, AdjuvantFemaleGastrointestinal Stromal TumorsHepatectomyHumansImatinib MesylateLiverLiver NeoplasmsTomography, X-Ray ComputedTreatment OutcomeImatinib Mesylate
What OpenQuestion holds
Textmetadata
Read underepoch 390